Celgene (CELG) – Reuters
-
Bristol-Myers posts better-than-expected results, Opdivo growth slows
-
Wall Street bounces as trade temperature cools
-
Pfizer to spinoff, merge off-patent drugs unit with Mylan
-
Eliquis, Orencia sales propel Bristol-Myers to strong second quarter
-
Wall Street plunges as factory data, Apple warning fuel slowdown fears
-
FDA names drugmakers potentially acting to delay cheap generics
-
Wall Street slides as healthcare drags but manages monthly gain
-
Oil prices climb after Netanyahu announcement; stocks fall
-
Takeda sounds out banks for loans as it moves towards Shire bid: sources
-
Drugmaker Shire soars as Japan's Takeda considers bid
-
GlaxoSmithKline prescribes commercial reboot for pharma division
-
Wall Street slides late; S&P 500 caps worst month since Jan 2016
-
Stocks hit record as senators reach deal to end shutdown
-
$11 billion biotech binge fuels forecasts of 2018 M&A surge
-
Wall Street slips heading into holiday
-
Wall Street ends higher with help from tech, energy
-
Dow, S&P gain but Nasdaq dips as healthcare lags
-
U.S. tax plan hopes lift stocks, dollar strengthens
-
When it comes to U.S. stocks, growth trumps quality
-
Wall Street gains on data and Mnuchin tax reform remarks
-
Janus portfolio manager sees more biotech gains on Trump
-
Stocks dip as earnings pour in, consumer discretionary lags
-
Wall Street up on cautious Fed, upbeat data
-
Medivation agrees to open its books to Sanofi
-
Wall St. ticks up on economy bets; Brexit fear ebbs
-
Gilead shares look cheap but investors fret over growth
-
Wall Street snaps up shares in late-day scramble
-
Celgene, Gilead Sciences shares could rise 30 percent: Barron's
-
Dow, S&P 500 end up in late turnaround; Alcoa dips after hours
-
On Wall Street, oil proffers modest Santa Claus rally
-
Wall St slips after mixed earnings as jobs report looms
-
U.S. biotech bloodbath hits hedge funds but some bargains emerge
-
Wall Street's worst month in three years ends on a sour note
-
Hedge fund manager Bass defends targeting drug patents for profit
-
Wall Street edges lower as energy weighs
-
Futures steady ahead of Yellen speech, Greek vote
Back to CELG Stock Lookup